Page 3 of 5
12345

2019 (6 POSTS)

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, LA, May 2019.

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Pediatric Academic Societies, Baltimore, MD, April 2019.

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Celebration of Pediatric Pulmonology and Sleep, Orlando, FL, February 2019.

2018 (2 POSTS)

Ambrose C, Jiang X, Mavunda K. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. ID Week, San Francisco, CA, October 4, 2018.

Ruzin A, Pastula ST, Levin-Sparenberg EM, Jiang X, Fryzek JP, Tovchigrechko A, Lu B, Qi Y, et al. 2018. Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS One 13(7):e0200319; doi: 10.1371/journal.pone.0200319. PMID: 30040837.

View Abstract

2017 (5 POSTS)

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort. Presented at the American Society of Hematology, Atlanta, GA, December 2017.

Ruzin A, Levin-Sparenberg E, Pastula S, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Yu L, et al. Characterization of RSV strains among U.S. patients in the OUTSMART RSV program during 2015-16. Abstract and poster presentation, ID Week 2017, San Diego, CA, October 2017.

Mullins M, Jiang X, Bylsma LC, Fryzek JP, Reichert H, Chen EC, Kummar S, Rosenthal A. 2017. Cold agglutinin disease burden: A longitudinal analysis of anemia, medications, transfusions, and healthcare utilization. Blood Adv 1(13):839-848; doi: 10.1182/bloodadvances.2017004390. PMID: 29296728.

View Abstract

Friedman D, Fryzek J, Jiang X, Bloomfield A, Ambrose CS, Wong PC. 2017. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One 12(3):e0172512; doi: 10.1371/journal.pone.0172512. PMID: 28253361.

View Abstract

Pastula ST, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. 2017. Hospitalizations for respiratory syncytial virus disease among adults in the United States, 1997 to 2012. Open Forum Infect Dis 4(1):ofw270; doi: 10.1093/ofid/ofw270. PMID: 28480262.

View Abstract

2016 (4 POSTS)

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Abstract and poster presentation, International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) 2016 — Options IX for the Control of Influenza, Chicago, IL, August 2016.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Abstract and poster presentation, International Society for Pharmacoeconomics (ISPOR), Washington, DC, May 2016.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Abstract and poster presentation, ID Week 2016, New Orleans, LA, October 2016.

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. 2016. Trends in respiratory syncytial virus and bronchiolitis hospitalization rates in high-risk infants in a United States nationally representative database, 1997-2012. PLoS One 11(4):e0152208; doi: 10.1371/journal.pone.0152208. PMID: 27050095.

View Abstract

2015 (3 POSTS)

Fryzek J, Doucette A, Jiang X, Coalson J, McLaurin K, Ambrose CS. Trends in respiratory syncytial virus and bronchiolitis infant hospitalization rates in high-risk infants in a US nationally representative database (1997–2012). Presented at ID Week, San Diego, CA, October 2015.

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Comparison of trends in bronchiolitis and respiratory syncytial virus infant hospitalizations rates in 3 US nationally representative databases. Presented at the Pediatric Academic Societies Annual Meeting, San Diego, CA, April 2015.

Demond A, Jiang X, Broadwater K, Meeker J, Luksemburg W, Maier M, Garabrant D, Franzblau A. 2015. Serum concentrations of polychlorinated dibenzo-p-dioxins among ceramicists. Chemosphere 118(Jan):350-356; doi: 10.1016/j.chemosphere.2014.09.074. PMID: 25463261.

View Abstract

2014 (2 POSTS)

Alexander DD, Jiang X, Bylsma LC, Garabrant DH, Irvin SR, Fryzek JP. 2014. Historical cancer incidence and mortality assessment in an Illinois community proximal to a former manufactured gas plant. BMJ Open 4(12):e006713. doi: 10.1136/bmjopen-2014-006713. PMID: 25534215.

View Abstract

Cohen SS, Sadoff MM, Jiang X, Fryzek JP, Garabrant DH. 2014. A review and meta-analysis of cancer risks in relation to Portland cement exposure. Occup Environ Med 71(11):796-802; doi: 10.1136/oemed-2014-102193. PMID: 25143515.

View Abstract

2013 (4 POSTS)

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Response to Goldstein et al. J Occup Environ Med 55(11):1378; doi: 10.1097/JOM.0000000000000021. PMID: 24202246. PMID: 24202246.

View Abstract
Page 3 of 5
12345